114 results match your criteria: "California§NW Headache and Wellness Center||Siker Medical Imaging[Affiliation]"
Front Psychol
June 2017
Department of Clinical and Experimental Medicine, University of FoggiaFoggia, Italy.
Previous studies suggested that movement velocity influence space perception. We examined whether healthy participants used velocity information when they were asked to reproduce a previously performed movement. Two experiments were carried out.
View Article and Find Full Text PDFHeadache
July 2017
Scion NeuroStim, LLC, Raleigh, NC.
Objective: To evaluate the safety and efficacy of a novel solid-state, caloric vestibular stimulation (CVS) device to provide adjuvant therapy for the prevention of episodic migraine in adult migraineurs.
Background: Migraine causes significant disability in ∼12% of the world population. No current migraine preventive treatment provides full clinical relief, and many exhibit high rates of discontinuation due to adverse events.
J Headache Pain
December 2017
Medical Toxicology - Headache Centre, Policlinic Hospital, University of Modena and Reggio Emilia, Modena, Italy.
Background: Headache disorders are highly prevalent, and have a substantial and negative impact on health worldwide. They are largely treatable, but differences in structure, objectives, organization and delivery affect the quality of headache care. In order to recognize and remedy deficiencies in care, the Global Campaign against Headache, in collaboration with the European Headache Federation, recently developed a set of quality indicators for headache services.
View Article and Find Full Text PDFJ Altern Complement Med
September 2016
4 Department of Clinical Pharmacy, University of California , San Francisco, School of Pharmacy, San Francisco, CA.
Objectives: Chinese herbal medicine (CHM) use has not been well characterized in persons living in the United States who receive care by Western-trained healthcare providers. The primary objective of this study was to characterize use of CHM taken in the last 12 months by patients seen at a Chinatown public health center.
Design: Convenience sample survey.
J Headache Pain
October 2016
Department of Medico-Surgical Sciences and Biotechnologies, "Sapienza" University of Rome Polo Pontino, Latina, Italy.
Background: Here, we aim to identify cortical electrofunctional correlates of responsiveness to short-lasting preventiveintervention with ketogenic diet (KD) in migraine.
Methods: Eighteen interictal migraineurs underwent visual (VEPs) and median nerve somatosensory (SSEPs) evokedpotentials before and after 1 month of KD during ketogenesis. We measured VEPs N1-P1 and SSEPs N20-P25 amplitudes respectively in six and in two sequential blocks of 100 sweeps as well as habituation as theslope of the linear regression between block 1 to 6 for VEPs or between 1 to 2 for SSEPs.
J Neurotrauma
January 2017
1 Faculty of Health Sciences, Ministry of Health, Anxiety and Stress Research Unit, Ben-Gurion University of the Negev, Beer-Sheva, Israel .
The intense focus in the clinical literature on the mental and neurocognitive sequelae of explosive blast-wave exposure, especially when comorbid with post-traumatic stress-related disorders (PTSD) is justified, and warrants the design of translationally valid animal studies to provide valid complementary basic data. We employed a controlled experimental blast-wave paradigm in which unanesthetized animals were exposed to visual, auditory, olfactory, and tactile effects of an explosive blast-wave produced by exploding a thin copper wire. By combining cognitive-behavioral paradigms and ex vivo brain MRI to assess mild traumatic brain injury (mTBI) phenotype with a validated behavioral model for PTSD, complemented by morphological assessments, this study sought to examine our ability to evaluate the biobehavioral effects of low-intensity blast overpressure on rats, in a translationally valid manner.
View Article and Find Full Text PDFPediatr Neurol
March 2016
Center for Integrative Health and Wellness, The Ohio State University and Nationwide Children's Hospital, Columbus, Ohio; Department of Medicine, The Ohio State University and Nationwide Children's Hospital, Columbus, Ohio.
Background: Our aim was to describe the relationship between risk factors, such as stress, depression, and anxiety, and potentially protective factors against pediatric headache-related disability, such as mindfulness, resilience, and self-compassion, and to determine teens' interest in mind-body skills training to help reduce headache-related disability.
Methods: This was a cross-sectional survey among adolescents seen in an academic neurology clinic reporting four or more headaches monthly using standardized instruments to determine the relationship between putative risk and protective factors as well as physiologic markers of inflammation and vagal tone and headache-related disability.
Results: Among the 29 participants, 31% were male, the average age was 14.
PLoS One
July 2016
Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania United States of America.
Mild Traumatic Brain Injury (mTBI) is a prominent public health issue. To date, subjective symptom complaints primarily dictate diagnostic and treatment approaches. As such, the description and qualification of these symptoms in the mTBI patient population is of great value.
View Article and Find Full Text PDFOtol Neurotol
January 2016
*Ear and Skull Base Center, and Legacy Research Institute, Portland, Oregon†Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania‡Department of Psychology, Azusa Pacific University, Azusa, California§NW Headache and Wellness Center||Siker Medical Imaging, Portland, Oregon, U.S.A.
Objective: Patients with peripheral vestibular dysfunction because of gravitational receptor asymmetries display signs of cognitive dysfunction and are assumed to have neurobehavioral sequelae. This was tested with pre- and postoperatively quantitative measurements in three cohort groups with superior semicircular canal dehiscence syndrome (SSCDS) symptoms with: 1) superior canal dehiscence (SCD) repaired via a middle cranial fossa craniotomy and canal plugging only; 2) otic capsule defects not visualized with imaging (no-iOCD) repaired with round window reinforcement (RWR) only; or 3) both SCD plugging and subsequent development of no-iOCD followed by RWR.
Study Design: Prospective patient series.
Gastroenterology
February 2016
Mount Sinai Beth Israel, New York, New York.
Background & Aims: The interferon-free regimen of simeprevir plus sofosbuvir was recommended by professional guidelines for certain patients with hepatitis C virus (HCV) genotype 1 infection based on the findings of a phase 2 trial. We aimed to evaluate the safety and efficacy of this regimen in clinical practice settings in North America.
Methods: We collected demographic, clinical, and virologic data, as well as reports of adverse outcomes, from sequential participants in HCV-TARGET--a prospective observational cohort study of patients undergoing HCV treatment in routine clinical care settings.
Mil Med Res
September 2015
Brain Wellness and Biofeedback Center of Washington, 7910 Woodmont Ave #305, Bethesda, MD 20814 USA.
Background: Chronic headache following traumatic brain injury (TBI) sustained in military service, while common, is highly challenging to treat with existing pharmacologic and non-pharmacologic interventions and may be complicated by co-morbid posttraumatic stress. Recently, a novel form of brainwave-based intervention known as the Flexyx Neurotherapy System (FNS) that involves minute pulses of electromagnetic energy stimulation of brainwave activity has been suggested as a means to address symptoms of TBI. This study reports on a clinical series of patients with chronic headache following service-connected TBI treated with FNS.
View Article and Find Full Text PDFJ Occup Environ Med
January 2015
From the Colorado School of Public Health, Center for Worker Health and Environment and Department of Environmental and Occupational Health (Drs Newman, Metcalf, and Witter, Ms Tenney), Aurora; Tri-County Health Department (Ms Stinson), Greenwood Village, Colo; Health Science Center, Peking University (Dr Fang) Beijing, China; Segue Consulting (Ms Brockbank), Denver, Colo; Integrated Benefits Institute (Dr Jinnett), San Francisco, Calif; Department of Environmental and Radiological Health Sciences (Dr Reynolds), Colorado State University, Fort Collins; Trotter Wellness (Ms Trotter), Sheboygan, Wisc; Department of Health Systems, Management & Policy (Dr Atherly), Colorado School of Public Health, Aurora; and Truven Health Analytics and Institute for Health and Productivity Studies, Johns Hopkins University, Bloomberg School of Public Health (Dr Goetzel), Bethesda, Md.
Objective: To assess small business adoption and need for a worksite wellness program in a longitudinal study of health risks, productivity, workers' compensation rates, and claims costs.
Methods: Health risk assessment data from 6507 employees in 260 companies were examined. Employer and employee data are reported as frequencies, with means and standard deviations reported when applicable.
Background: Recent studies evaluated short-term efficacy and safety of peripheral nerve stimulation (PNS) of the occipital nerves for managing chronic migraine. We present 52-week safety and efficacy results from an open-label extension of a randomized, sham-controlled trial.
Methods: In this institutional review board-approved, randomized, multicenter, double-blinded study, patients were implanted with a neurostimulation system, randomized to an active or control group for 12 weeks, and received open-label treatment for an additional 40 weeks.
Curr Treat Options Neurol
February 2013
Lankenau Medical Center and Lankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA, 19096, USA,
The Refractory or Intractable Migraine (RM) patient has long been a challenge to all healthcare providers (HCP). Headache specialists have recognized this sub group of patients who remain refractory to treatment. Despite this recognition, there are no formal criteria that characterize RM.
View Article and Find Full Text PDFJAAPA
February 2012
Headache Wellness Center, Greensboro, North Carolina, USA.
Maturitas
April 2012
Millennium Wellness Center, 228 E. Spring Valley Road, Dayton, OH 45458, USA.
The purpose of this prospective pilot study was to determine the therapeutic effect of continuous testosterone, delivered as a subcutaneous implant, on the severity of migraine headaches in pre- and post-menopausal patients. Twenty-seven women with a history of documented migraine headache were asked to rate their headache severity using a five-point scale at baseline (prior to therapy); and again, 3 months following treatment with testosterone implants. Improvement in headache severity was noted by 92% of patients and the mean level of improvement was statistically significant (3.
View Article and Find Full Text PDFWomens Health (Lond)
September 2011
Carolina Women's Research & Wellness Center, Durham, NC 27713, USA.
Aims: An open-label, extension clinical study was conducted to assess the safety of a novel, oral formulation of tranexamic acid (TA) in women with cyclic heavy menstrual bleeding.
Patients & Methods: Eligible patients who completed either a three- or six-cycle double-blinded clinical trial of TA were offered enrollment into a study of nine cycles with TA (1.3 g orally three times/day for a maximum of 5 days per cycle).
Womens Health (Lond)
November 2011
Carolina Women's Research & Wellness Center, Durham, NC 27713, USA.
Aims: A multicenter, long-term, open-label study was conducted to assess the safety and health-related quality of life (HRQoL) of an oral tranexamic acid (TA) formulation in women with cyclic heavy menstrual bleeding (HMB).
Materials & Methods: Following a screening menstrual cycle, women with a history of cyclic HMB initiated 27 cycles of treatment with TA 1.3 g administered three-times daily for up to 5 days per menstrual cycle (maximum of 15 doses).
Pain Med
March 2008
Headache Wellness Center, Greensboro, North Carolina 27405, USA.
Objective: Topiramate is an effective and generally well-tolerated migraine preventive therapy, as shown in three large, randomized, double-blind, placebo-controlled registration trials. Based upon efficacy/tolerability, topiramate 100 mg/day (50 mg BID) is the recommended target dose for most patients with migraine. To further assess the safety and tolerability of topiramate for migraine prevention, we analyzed safety data from 1,580 patients who participated in the three pivotal registration trials or an earlier pilot, randomized, double-blind, placebo-controlled trial.
View Article and Find Full Text PDFHeadache
February 2009
Headache Wellness Center, Greensboro, NC 27405, USA.
Background: Since November 2002, Headache Wellness Center, a specialty headache practice in Greensboro, NC, has used exclusively an electronic medical record (EMR) system for all patient clinical contacts.
Objective: To assess patient satisfaction and perceptions regarding this new office technology and to better understand the EMR-patient-physician relationship.
Methods: An EMR satisfaction survey was administered from February to June 2006 and was completed by 394 patients.
Headache
September 2007
Headache Wellness Center, Greensboro, NC 27405, USA.
Objective: This case series is a retrospective chart analysis conducted to evaluate the efficacy of duloxetine as a migraine preventive medication and to suggest possible predictors of response.
Background: Duloxetine, a relatively new selective serotonin and norepinephrine reuptake inhibitor, is FDA-approved for treatment of depression and diabetic peripheral neuropathic pain. The efficacy of duloxetine as a headache preventive medication is currently unknown.
Pediatr Clin North Am
February 2005
School of Health Services Administration and Policy, Student Health and Wellness Center, W.P. Carey School of Business, Arizona State University Main Campus, PO Box 872104, Tempe, AZ 85287-2104, USA.
The college health physician cares for college students who present with a wide variety of medical disorders. This article reviews the management of four common medical problems: infectious mononucleosis, asthma, migraine headaches, and urinary tract infections. College students can become ill, and it is important that they have health care services designed to deal with their health care issues.
View Article and Find Full Text PDFHeadache
June 2005
Headache Wellness Center, Greensboro, NC, USA.
Migraine preventive medications considered effective reduce headache frequency by 50 percent in approximately 50 percent of treated patients. In spite of similar effectiveness, these medications vary tremendonsly in their prices. Knowledge of medication prices and employing cost-effective strategies may greatly reduce treatment costs.
View Article and Find Full Text PDFHeadache
March 2004
Headache Wellness Center, Greensboro, NC 27401, USA.
Objective: To provide medication price data and cost-reducing strategies for the acute treatment of migraine.
Methods: Retail prices for common acute care medications were found at http://www.drugstore.
Headache
January 2004
Headache Wellness Center, Greensboro, NC, USA.
Some patients have headaches that are refractory to standard treatments, and they require chronic administration of opioid analgesics. The use of opioids in a clinical setting must be closely monitored due to the medications' potential for addiction, abuse, and fatal interactions. Limited access to opioids and the demand for them outside the clinical setting leads to another danger.
View Article and Find Full Text PDF